Labcorp Holdings (LH) stock

Clinical lab tests , market cap $29B

Clinical lab tests and patient-service centers

Worth $29B

$370.88

-0.26%

As of Tuesday's close · Live for Pro members at the open

Quality Score

Excellent

In its industry

#3of 18

Diagnostics

Checks firing

7of 14

Trending up

From 52-week high

-0.8%

under its best in a year

LH's Quality Score was unchanged on Tue, Nov 10, at 16.

See LH's 14 chart checksSee it live, free until Thursday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Why LH rose on Oct 28

Up 9% on Oct 28, and still 12% over its Oct 27 close.

Its Oct 28 results: revenue was $3.81B, from $3.56B a year before; earnings per share were $3.22, from $3.12. It rose 9% on Oct 28.

Sources: Price history, Oct 28, 2026; Company release, Oct 28, 2026

1 more reason, free with an account →3 more reasons why LH rose on Oct 28, from its filings, with the timeline and its peers, for Pro members.

Key facts on LH

Key facts on LH
Outperforming	Up 44% in 6 months vs the S&P's +2%
Latest filing	10-Q, Oct 30 Filed its quarterly report (10-Q) for the quarter to Sep 30, 2026

1 more reason behind LH's 16, free with an account →3 more reasons behind LH's 16, for Pro members.

LH in the news

Wed Oct 28Labcorp Reports Strong 2026 Third Quarter Results; Raises Full Year 2026 Guidance SEC filing 6:57 AM ET · PR Newswire and 5 more LH closed +8.8% that day.

Big story

Guidance

Labcorp Q3 Adjusted Earnings, Revenue Rise; 2026 Guidance Raised

LH closed +8.8% that day on 2.5x normal volume.

Reported by Yahoo Finance · covered by 9 outlets

Get an alert on LH's next big story →

Outlet counts from the GDELT Project. The move is what LH did that session, not a claim about why.

What's next

Tue Nov 24: Ex-dividend, $0.72 a shareAt the open. Pays Dec 11.

LH catalysts

Coming up

After its last 4 reports it closed +2.3% on average, higher 2 of 4 times.

33 past catalysts since 2018, with sizes and sources, for Pro members.

Why LH scores 16

Excellentfor quality, not price, 7 of 14 chart checks firingWhat the Quality Score means

+7Chart checks 7 of 14 firing right now, one point each
+4Long-term trend above a rising 200-⁠day average, near its 52-⁠week high, at a multi-⁠year high

Run-up adds
Size adds
Profit addsRead on the last four quarters against the four before, or the last full year where no quarters are filed.
Persistence adds

No effect today: Growth, Dilution, Volatility, Cash flow, News, and Insider trades.

What every line is worth, and the reason behind it, on LH and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 10:56 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-scored stocks returned 2.2x the average stock over the next month. Reconstructed after the fact; recorded live since Sep 9, 2026. How we tested it

Alert me when LH's Quality Score turns up

A free account. No card.

How LH ranks in Diagnostics

LH is #3 of 18 by Quality Score.

How LH ranks in Diagnostics
Rank	Stock	Checks	Quality Score
1	CDNACareDx	4/14	16
2	BLLNBillionToOne	5/14	16
3	LHLabcorp	7/14	16
	GHGuardant Health		Open for its score
	GRALGRAIL		Open for its score
	LMRILumexa Imaging		Open for its score
	NTRANatera		Open for its score

Share count against a year before: LH -2.4%, GRAL +29%, GH +7.7%, DGX -1.8%.

When does LH report earnings, and what happens after?

Expected to report Tue Feb 23, before the open (in 105 days).

What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.

What LH reported on Oct 28, 2026

The quarter

Sales of $3.8B, 7% more than a year ago; a profit of $3.22 a share, from $3.12.

The quarter that ended Sep 30, from the company's press release

The press release The filing on EDGAR

Where the sales came from

Where the quarter's sales came from
Line	Q3 2026	Q2 2026	Q3 2025
By segment
Diagnosticsup 6.5%	$2.9B77%	$2.9B78%	$2.8B78%

Each quarter's sales and their share of its total. Figures as filed (SEC filing, Oct 30)

1 more line, for Pro members.

The outlook

No outlook figures read from this release.

The numbers

Market value: $29B; today
Sales: $15B; up 6% on the year
Free cash flow: $1.3B; last 12 months

Sales held about even over 5 years, fiscal 2020 to 2025.

Pays $2.88 a share a year.

5 more figures, for Pro members.

No analyst estimates on Breakaway: every figure here is filed.

The whole report on LH: every line of its sales, every outlook beside the one it replaced, and the company's words, for Pro members.

Close after the report, last 3

-0.1%+2.7%+8.8%

Apr 30Jul 30Oct 28

Reported	When	Gap	Reaction	5 days
Oct 28, 2026Before open	Before open	+4.0%	+8.8%	+6.9%
Jul 30, 2026Before open	Before open	-3.0%	+2.7%	+2.2%
Apr 30, 2026Before open	Before open	+2.9%	-0.1%	-0.1%

LH closed higher after 2 of its last 4 reports.

All 4 reports, and LH's Quality Score going into each

LH sales and profit by year

Sales and profit by year

Sales grew in five of the last seven years, to $14B in 2025. It made a profit in each of the eight years.

LH has 7 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on LH, and all 14 on every stock.Get in free →

LH RSI today: 71.1, above its 50-day and 200-day averages

Not scored

RSI 71.1, MACD above signal, above both averages. Not scored.13 readings

The deep dive on LH

What it does and how it makes money2 findingsIt kept 10 cents of each dollar of sales in fiscal 2025: $1.38B of operating profit on $14.0B of sales.Annual report, filed Feb 24, 2026
Where it stands5 findingsFor Pro members5 findings on where LH stands: its cash, debt, and share count, for Pro members
What changed in its filings3 findings"The United States Court of Appeals for the Federal Circuit has scheduled oral argument on the Company’s appeal for December 15, 2026." (10-Q for the quarter to Sep 30, 2026)SEC filing · Oct 30, 2026
Who holds and trades it4 findingsFor Pro members4 findings on who holds and trades LH, for Pro members
Against its closest peers3 peersShare count against a year before: LH -2.4%, GRAL +29%, GH +7.7%, DGX -1.8%.

12 more findings on LH, each with its source, for Pro members.

LH insider trades

3 insiders sold $1.1M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest:

SellRichelle P. Parham$389KDirectorat $361.22 on Oct 30, filed Nov 3

SellRichelle P. ParhamDirector$389Kat $361.22 on Oct 30, filed Nov 3

All 4 insider filings on LH from the last six months, for Pro members.

All LH insider trades

LH trades by Congress and the executive branch

10 trades disclosed in the last six months. The newest:

BuyRo Khanna$1K to $15KHousetraded Sep 4, disclosed Oct 7(33 days later)

BuyRo KhannaHouse$1K to $15Ktraded Sep 4, disclosed Oct 7(33 days later)

All 10 trades on LH disclosed by Congress and the executive branch, for Pro members.Get in free →

See what Congress is buying across the market

LH's officers and directors

Officers and directors with a Form 4 in the last 12 months.

Adam H. SchechterPresident & CEO · 5 trades
Julia Aijun WangChief Financial Officer, EVP · no trades on file
Jonathan C. MeltzerEVP, Operations · 4 trades
Peter J. WilkinsonSVP, Chief Accounting Officer · 4 trades
Bryan T. VaughnEVP and President, Diagnostics · 2 trades
Kathryn W. KyleEVP, Chief Legal Officer · 2 trades
Amy B. SummyEVP, Chief Marketing Officer · 1 trade
Brian J. CaveneyEVP, Pres of ED, CMO & CSO · 1 trade

13 more officers and directors file at LH.

See insider trades by person

Which ETFs hold LH?

In ETFs: LH is under 0.1% of IVV, under 0.1% of SPY, and under 0.1% of VOO, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026 (SPY's as filed by IVV).

About Labcorp Holdings

Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from uncomplicated routine blood and urine screens to complex oncology and genomic testing.

71,000 employeesBurlington, NClabcorp.com

Here is what Pro members see.

The same page for Pro members, on Microsoft
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on LH and every other stock.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

Pro members see every line of every stock's score.

What would move LH's score: 4 things
6 more filings explained, a plain line each
Real-⁠time prices, no delay

BreakawayOct 7Ro Khanna bought LH$1K to $15K, disclosed Oct 7

Alerts are optional.

See LH's 14 chart checks

See it live, free until Thursday morning. No account. No card. Then keep going with a free account.

Straight AnswersStraight Answers

As of Nov 10, 2026: LH's Quality Score is 16 (Excellent), #3 of 18 in Diagnostics. Insiders sold $1.1M in the last 6 months (Form 4).

What does LH's Quality Score say?

LH scores 16 today, which Breakaway calls Excellent. It is #3 of 18 in Services-⁠Medical Laboratories by Quality Score, with 7 of 14 chart checks firing. Up 9% on Oct 28, and still 12% over its Oct 27 close. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is LH's Quality Score?

LH scores 16 today, which Breakaway calls Excellent (15 to 19). That is #3 of 18 in Services-⁠Medical Laboratories by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind LH's 16.

Are insiders buying LH?

3 insiders sold $1.1M across 4 filings in the last 6 months. No open-⁠market buys on record. The newest is Richelle P. Parham, Director, who sold $389K on Oct 30. Every filing, with the scored weight, for Pro members.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.